Why Parkinson's

We believe in clinical evidence, we provide reliable treatments, we use safe technology.

I'm PINE, are you fine?

Parkinson's disease(PD) is currently the fastest-growing neurodegenerative disease in the world, characterized by a range of motor and non-motor symptoms, still without a cure. It typically begins between the ages of 55 and 65, affecting about 1-1.5% of the population over 65 worldwide. In Korea, approximately 150 thousand individuals are affected, and globally, the number exceeds 10 million.

Non-pharmacological treatments for PD are as necessary as pharmacological treatments but are currently not sufficiently provided. This is because there are not enough medical institutions that offer proper non-pharmacological treatments, most patients have mobility challenges to visit hospital, and there is the cost issue for in-person treatment.

Parkinson's disease chart
Parkinson's disease research

Research

Our clinical studies ensure the need for and the adherence to digital therapy among patients with PD

Our neurologists and researchers have published studies on telemedicine and digital therapeutics in SCI-indexed journals on PD.

01.

Feasibility and efficacy of video-call speech therapy in patients with Parkinson's disease: A preliminary study
Chang at al., 2023, Parkinsonism and related disorders
02.

A Survey of Perspectives on Telemedicine for Patients With Parkinson’s Disease
Joo at al., 2023, J Mov Disorder
03.
Smartphone Application–Based Voice and Speech Training Program for Parkinson Disease: Feasibility and Satisfaction Study With a Preliminary Rater-Blinded Single-Arm Pretest and Posttest Design
Lee at al., 2025, Journal of Medical Internet Research
04.
Exploring Spectrogram-Based Audio Classification for Parkinson’s Disease: A Study on Speech Classification and Qualitative Reliability Verification
Jeong at al., 2024, Sensors
05.
Hospital utilization and telemedicine preferences in patients with late-stage Parkinson’s disease and caregivers
Hong at al., 2024, Clinical Parkinsonism & Related Disorders
06.
A cross-language speech model for detection of Parkinson's disease
Lim et al., 2024, Journal of Neural Transmission
07.
Machine learning-based classification of Parkinson’s disease using acoustic features: Insights from multilingual speech tasks
Jeong at al., 2024, Computers in Biology and Medicine

Products

PINE aims to create a "Virtual Parkinson's Hospital" that provides digital PD treatments on a single platform.


AI-powered digital therapeutics have the potential to enhance non-pharmacological home treatment more effectively for speech-language, exercise, and psychological issues in individuals living with PD.

product

Software as a Medical Device to improve Speech-Langauge disorders in PD

PINE SPEECH®


PINE SPEECH® uses an automated patient-driven treatment system without human intervention, evaluating the speech-language disorder of PD patients and to provide patient-tailored treatment, and provides medical reports on patient evaluation and treatment results to doctors.


PINE SPEECH® is intended to be a Class 2 medical device approved by a regulatory body with proven medical effectiveness and safety, and used by patients at home after prescription from a doctor at hospital.

Parkinson's disease product
Parkinson's disease product

A patient-tailored digital Speech-Language Therapy (SLT) protocol, consisting of treatment for breathing, oral motor, strength, pitch, and pronunciation.


A conversational treatment led by an AI medical chatbot with PD voice recognition will enhance adherence to digital therapy.


UI/UX was developed complying with digital accessibility for the elderly individuals with PD.



Software as a Medical Device to improve Speech-Langauge disorders in PD

PINE SPEECH®


PINE SPEECH® uses an automated patient-driven treatment system without human intervention, evaluating the speech-language disorder of PD patients and to provide patient-tailored treatment, and provides medical reports on patient evaluation and treatment results to doctors.


PINE SPEECH® is intended to be a Class 2 medical device approved by a regulatory body with proven medical effectiveness and safety, and used by patients at home after prescription from a doctor at hospital.

Parkinson's disease product

A patient-tailored digital Speech-Language Therapy (SLT) protocol, consisting of treatment for breathing, oral motor, strength, pitch, and pronunciation.


A conversational treatment led by an AI medical chatbot with PD voice recognition will enhance adherence to digital therapy.


UI/UX was developed complying with digital accessibility for the elderly individuals with PD.

Parkinson's disease product

Leadership

PINE is a digital therapeutics company co-founded by a professor of neurology at Seoul National University Hospital and a former C-level at large platforms and strategic consulting firm.

CEO & Co-Founder

Han-Joon Kim, MD, PhD

Seoul National University, College of Medicine, PhD (Neuroscience)

Professor at Seoul National University, College of Medicine
and Seoul National University Hospital (Neurology)

Medical Director at Movement Disorders Center
at Seoul National University Hospital

Secretary of the Asian-Oceanean Secion of International Parkinson's Disease Society

CTO & Co-Founder

Young-Ho Seo, MS in Eng.

Seoul National University, School of Engineering, MS (Industrial Eng.)

Chief Technology Officer at Culture Commerce, YES24.com

Chief Technology Officer at English Edutech, Creverse

Chief Operation Officer at Job Portal, AlbaParadise

Director Consultant at SK Corp. Valtech Consulting

Medical Advisor

Woongwoo Lee, MD, PhD

Seoul National University, College of Medicine, PhD (Neurology)

Professor at Nowon Eulji Medical Center (Neurology)

Jin-Woo Park, MD, PhD

Seoul National University, College of Medicine, PhD (Rehabilitation)

Professor at Donguk University Ilsan Hospital (Rehabilitation)

Youngeun Kim, MD, PhD

Seoul National University, College of Medicine, PhD (Neurology)

Professor at Hallym University Hospital (Neurology)

Jaeyong Shin, MD, MPH, PhD

Yonsei University, College of Medicine, PhD (Preventive Medicine)

Professor at Yonsei University (Preventive Medicine)

Company

PINE has demonstrated its technological capabilities and business viability.

History

  • 2025

    06 Certification of Korea Manufacturing and
    Quality System (KGMP) for medical device
    05 Seleted for 'Digital Therapeutics Development &
    Verification' project by Ministry of Science and Technology
    05 Usability summative evaluation for
    PINE SPEECH® v1.0
    04 Selected for 'AI Voucher Project'
    by Ministry of Science and Technology
    04 Parkinson's speech-language digital therapeutics,
    PINE SPEECH® v1.0 released

  • 2024

    12 Establishment of corporate research institute
    11 Venture company certification by KOVA
    10 Selected for Deeptech TIPS project sponsored by
          Ministry of SMEs and Startups (R&D fund KRW 1.8 bln.)
    08 Seed funding - Medytox Venture Investment and HG Initiative
    06 PINE digital health incorporated

  • 2023

    Q4 Feasibility testing for elderly 25 PD patients in
    Seoul National University Hospital
    Q3 Development of MVP for PD speech-language treatment

  • 2022

    Q3 Preliminary clinical study on
          PD speech-language remote treatment


History


2025

06 Certification of Korea Manufacturing and Quality System (KGMP) for medical device
05 Seleted for 'Digital Therapeutics Development & Verification' project by Ministry of Science and Technology
05 Usability summative evaluation for PINE SPEECH® v1.0
04 Selected for 'AI Voucher Project' by Ministry of Science and Technology
04 Parkinson's speech-language digital therapeuctis PINE SPEECH® v1.0 released

2024

12 Establishment of corporate research institute
11 Venture company certification by KOVA
10 Selected for Deeptech TIPS project sponsored by Ministry of SMEs and Startups (R&D fund KRW 1.8 bln.)
08 Seed funding - Medytox Venture Investment and HG Initiative
06 PINE digital health incorporated

2023

Q4 Feasibility testing for elderly 25 PD patients in Seoul National University Hospital
Q3 Development of MVP for PD speech-language treatment

2022

Q3 Preliminary clinical study on PD speech-language remote treatment

Partners

Media

KBS1, January 8, 2025
Parkinson's speech-language digital therapeutics on TV
"I Have Parkinson's disease" appeared on popular TV health program, 'The Secret of a Birth, Aging, Illness, and Death'
Professor Han-Joon Kim is treating a Parkinson's patient with speech-language disorder using a prototype mobile app.
A female patient who has difficulty communicating in daily life is using a digital therapy app to self-treat herself by practicing speaking long and loudly.

PINE digital health Inc.

PINE digital health is a digital therapeutics company powered by AI to create innovative treatment experiences for individuals with Parkinson's Disease.

PINE digital health Inc.

(04768) G411, 115 Wangsimni-ro, Seongdong-gu, Seoul,
Republic of Korea

Business Registration Naumber : 564-81-03102
CEO : Han-Joon Kim
CTO : Young-Ho Seo
Contact : contact@pinedh.com

© PINE digital health, Inc. 2025 All Rights Reserved.